Pharmaceutical giant Pfizer has received U.S. approval for a gene therapy against a form of hemophilia, a rare and inherited blood clotting disorder, the company said Friday. Beqvez, which is given as a single intravenous infusion, was shown in a clinical trial of 45 people to be better at (...)
Site référencé: Raw Story
Raw Story
GOP warned Trump will let them take the fall if polls don't turn around
4/07/2025
'It's just not there' : Fact-checker shuts down Trump's budget claims
4/07/2025
Trump 'doesn't care' if abandoned GOP seats are won by Democrats : ex-senator
4/07/2025
Hegseth 'blindsided' State Dept. with weapons claim : NBC
4/07/2025
GOP’s ‘big fold’ now a habit : report
4/07/2025
Dear Dems : Please chuck Schumer, before it's too late for us all
4/07/2025
